Publications by authors named "D Levoyer"
Article Synopsis
- Clinical observations indicate that individuals with schizophrenia have early disturbances in self-consciousness.
- A study using a double mirror setup compared self-other recognition in individuals with early onset schizophrenia (EOS), adult onset schizophrenia (AOS), and typical controls.
- Results showed that both EOS and AOS individuals primarily focused on their own image, experiencing earlier recognition of self but delayed recognition of others, indicating self-other recognition impairments as a potential characteristic feature of schizophrenia.
Unlabelled: Despite the advantages of antipsychotic treatments via the injectable route of administration, there are still reservations regarding this type of therapy, notably among health professionals. A survey conducted with patients suffering from schizophrenic disorders revealed the positive opinion that they had of their treatment. Another survey showed that nearly half of the patients preferred an injectable form, and two thirds felt they were cared for better, because of the injectable treatment.
View Article and Find Full Text PDFObjective: "Michael's Game" is a card game which aims at familiarizing healthcare professionals and patients with cognitive therapy of psychotic symptoms. The present study tests the feasibility and the impact of the intervention in naturalistic settings.
Methods: 135 patients were recruited in 11 centres.
Introduction: Insight is more than frequently altered in schizophrenia, rupture of treatment being one the most known consequences of this impairment. Two different types of scales can be used to assess consciousness: self-questionnaires directly filled-in by the patient or questionnaires assessed by a psychiatrist after an interview. AIM OF THE STUDIES: The goal of this study was first to assess insight in schizophrenic patients with these two different types of scales and then try to find a link between insight impairment and schizophrenic symptoms.
View Article and Find Full Text PDFIntroduction: In this study, we present seven case reports concerning patients suffering from schizophrenia or schizo-affective disorders, treated by aripiprazole.
Study Design: Through these patient case reports, we have attempted to highlight the specificities of aripiprazole's action on schizophrenic symptoms, especially in the cognitive dimension. In acting as a regulator more than as a brake on the translation messages between neurons, aripiprazole does not increase cognitive disorders, but may have a procognitive affect.